News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
137 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8946)
Month
January (2936)
February (2969)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (52)
2 (69)
3 (217)
4 (182)
5 (111)
8 (114)
9 (128)
10 (133)
11 (79)
12 (60)
15 (68)
16 (117)
17 (107)
18 (176)
19 (54)
21 (1)
22 (84)
23 (141)
24 (76)
25 (137)
26 (62)
28 (7)
29 (111)
30 (95)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
21
22
23
24
25
26
28
29
30
Press Releases
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
September 25, 2025
·
3 min read
Press Releases
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
September 25, 2025
·
1 min read
Press Releases
LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
September 25, 2025
·
14 min read
Press Releases
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
September 25, 2025
·
7 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
September 25, 2025
·
4 min read
Press Releases
Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
September 25, 2025
·
9 min read
Press Releases
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
September 25, 2025
·
5 min read
Press Releases
Marengo to Present a Late-breaking Clinical Oral Abstract at ESMO 2025 on Initial Phase 2 Clinical Data of Invikafusp Monotherapy Activity in Patients with Antigen-Rich Solid Tumors Resistant to Immune Checkpoint Blockade
September 25, 2025
·
3 min read
Press Releases
Kura Oncology to Participate in Upcoming October 2025 Investor Conference
September 25, 2025
·
1 min read
Press Releases
Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292
September 25, 2025
·
10 min read
Previous
7 of 14
Next